RADAR

RADAR
RADAR provides health professionals with timely, independent, evidence-based information on new drugs and medical tests and changes to listings on the Pharmaceutical Benefits Scheme and Medicare Benefits Schedule.
All articles

Subscribe to NPS MedicineWise

Register to subscribe to email updates and hear about new medicines, topics and activities.

Register now
Latest full reviews

Molnupiravir (Lagevrio) for mild-to-moderate COVID-19

Molnupiravir (Lagevrio) for mild-to-moderate COVID-19
  • 7 March 2022
  • 10 minutes

Patients at high risk of severe disease are eligible for treatment (Updated 2 May 2022)

Dapagliflozin (Forxiga) for heart failure with reduced ejection fraction (LVEF ≤ 40%)

Dapagliflozin (Forxiga) for heart failure with reduced ejection fraction (LVEF ≤ 40%)

Dapagliflozin (Forxiga) for heart failure with reduced ejection fraction (LVEF ≤ 40%)

  • 27 December 2021

Palliative care: New, amended and deleted PBS items

Palliative care: New, amended and deleted PBS items

Palliative care: New, amended and deleted PBS items

  • 15 June 2021
  • 8 minutes

Opioids: New and amended PBS listings

Opioids: New and amended PBS listings

Opioids: New and amended PBS listings

  • 18 June 2020
  • 15 min read

Risperidone: Revised PBS restrictions for behavioural and psychological symptoms of dementia

Risperidone: Revised PBS restrictions for behavioural and psychological symptoms of dementia

Risperidone: Revised PBS restrictions for behavioural and psychological symptoms of dementia

  • 19 March 2020
  • 13 min read

Naloxone nasal spray (Nyxoid) for opioid overdose

Naloxone nasal spray (Nyxoid) for opioid overdose

Naloxone nasal spray (Nyxoid) for opioid overdose

  • 15 January 2020

Guanfacine (Intuniv) for attention deficit hyperactivity disorder

Guanfacine (Intuniv) for attention deficit hyperactivity disorder

Guanfacine (Intuniv) for attention deficit hyperactivity disorder

  • 18 October 2019
  • 10 min read
Wrap up
September 2022 New listing
  • 16 September 2022
PBS listing for hydroxychloroquine updated (2022)
  • 4 May 2022
February 2022 New listings
  • 7 February 2022
Tocilizumab (actemra) shortages: further temporary listings
  • 3 December 2021
Latest in brief
Dapagliflozin for chronic kidney disease
  • 1 September 2022
Changes to COVID-19 oral antiviral PBS eligibility criteria – July 2022
  • 13 July 2022
Clopidogrel and clopidogrel with aspirin now unrestricted on PBS
  • 17 May 2022
  • 10 mins
Nirmatrelvir and ritonavir (Paxlovid) for mild-to-moderate COVID-19
  • 2 May 2022

Subscribe to NPS MedicineWise

Register to subscribe to email updates and hear about new medicines, topics and activities.

Register now